Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Endothelial Progenitor Cell Therapy for Delayed Bone Defect Repair in a Pre-Clinical Rat Model
FY 2014-15
Summary
Large bone defects commonly occur following open bone fractures, and despite grafting treatment by orthopaedic surgeons, these defects often fail to heal, resulting in nonunion. With 100,000 nonunions occurring annually in the U.S., an alternative treatment is essential to improve clinical care. Endothelial progenitor cells (EPCs) are a novel type of stem/progenitor cell that are capable of inducing the formation of new blood vessels as well as new bone tissue, and have thus been proposed and investigated as a preferable treatment for bone defects.
Indeed, investigations in our lab have demonstrated the successful application of EPCs for enhancing fracture repair when these cells are applied acutely to a surgically created bone defect in a rat model. However, this may not completely replicate the situation that occurs clinically because bone defects are not typically treated in an acute setting due to an associated increase in infection rates.
My proposed project seeks to address this discrepancy by investigating the application of EPCs to a critical-sized bone defect 6 weeks following femur fracture surgery in rats. Briefly, I will implant EPCs on a biodegradable scaffold through surgical incision, as well as test a non-surgical, injectable delivery of EPCs in an attempt to reduce the invasiveness of the procedure. My hypothesis is that the application of EPCs to an established bone defect will result in bone repair and that injection of EPCs into the defect will provide comparable healing to the more invasive surgical procedure.
Successful use of EPCs in a clinically relevant model is necessary to help bring this regenerative therapy to clinic, and my study can serve as this critical stepping-stone.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
331237
Name
Bates Brent
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Endothelial Progenitor Cell Therapy for Delayed Bone Defect Repair in a Pre-Clinical Rat Model
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Angiogenesis; Bone Defect; Cell Therapy; Endothelial Progenitor Cells; Fracture Healing; Nonunion; Orthopaedics; Osteogenesis
Abstract
Large bone defects commonly occur following open bone fractures, and despite grafting treatment by orthopaedic surgeons, these defects often fail to heal, resulting in nonunion. With 100,000 nonunions occurring annually in the U.S., an alternative treatment is essential to improve clinical care. Endothelial progenitor cells (EPCs) are a novel type of stem/progenitor cell that are capable of inducing the formation of new blood vessels as well as new bone tissue, and have thus been proposed and investigated as a preferable treatment for bone defects.
Indeed, investigations in our lab have demonstrated the successful application of EPCs for enhancing fracture repair when these cells are applied acutely to a surgically created bone defect in a rat model. However, this may not completely replicate the situation that occurs clinically because bone defects are not typically treated in an acute setting due to an associated increase in infection rates.
My proposed project seeks to address this discrepancy by investigating the application of EPCs to a critical-sized bone defect 6 weeks following femur fracture surgery in rats. Briefly, I will implant EPCs on a biodegradable scaffold through surgical incision, as well as test a non-surgical, injectable delivery of EPCs in an attempt to reduce the invasiveness of the procedure. My hypothesis is that the application of EPCs to an established bone defect will result in bone repair and that injection of EPCs into the defect will provide comparable healing to the more invasive surgical procedure.
Successful use of EPCs in a clinically relevant model is necessary to help bring this regenerative therapy to clinic, and my study can serve as this critical stepping-stone.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bates, Brent
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~